Federal award
MEDPHARM INC.
HT941024P0043
Contract
Obligated and Ceiling
- Obligated (net)
- $228,820.09
- Ceiling (potential value, not spending)
- $228,820.09
- Current value
- $228,820.09
- Gross positive obligations
- $228,820.09
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- MEDPHARM INC. · DLM6VHZ3VUN3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- MEDPHARM INC. · DLM6VHZ3VUN3
- Awarding agency
- Department of War · sub-agency 97DH · office HT9410
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- HT941024P0043
- Award type code
- B
- Actions
- 4 · Dec 15, 2023 to Sep 18, 2024
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 18, 2024 | FY2024 | P00003 | M | $0.00 | — |
| Sep 17, 2024 | FY2024 | P00002 | B | $23,332.71 | — |
| Sep 13, 2024 | FY2024 | P00001 | B | $0.00 | — |
| Dec 15, 2023 | FY2024 | 0 | — | $205,487.38 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.